R.grid

R.grid The automation engine for admin-free clinical trials.

šŸ«€   Day | October 16, 2025In the UK, over 30,000 people experience an out-of-hospital cardiac arrest annually, with 80% ...
16/10/2025

šŸ«€ Day | October 16, 2025

In the UK, over 30,000 people experience an out-of-hospital cardiac arrest annually, with 80% occurring at home.
Early CPR and defibrillation can increase survival by two to three times, rising from less than 10% to over 30% when both are delivered (British Heart Foundation).

Restart a Heart, led by the Resuscitation Council UK, is an annual initiative that boosts survival from out-of-hospital cardiac arrests by teaching more people CPR and making them .

New trials on ECMO and advanced resuscitation continue to redefine what’s possible. This research helps identify what works, optimizes training, and guides vital public health interventions. It ensures both clinicians and communities are equipped to act effectively, improving survival and neurological outcomes after cardiac arrest.

🧬 A Historic Step Forward for Huntington’s Disease ResearchHuntington’s disease has long been one of the most devastatin...
25/09/2025

🧬 A Historic Step Forward for Huntington’s Disease Research

Huntington’s disease has long been one of the most devastating hereditary brain disorders. It usually strikes in your 30s or 40s, slowly destroying neurons and affecting movement, cognition, and behavior.

A groundbreaking gene therapy trial from UCL might have changed that. For the first time, doctors report a 75% slowing of disease progression in patients. Historically, treatments could only manage symptoms, never slow the disease itself.

While the treatment is still a long way from approval, the results mark an advance against the devastating genetic disease and offer hope for the thousands of families affected by Huntington’s.

Here are some surprising facts you might not know about the disease:
✨ Genetic lottery: If one parent has Huntington’s, there’s a 50% chance their child will inherit the altered gene.
🧬 Mutant protein culprit: The disease is caused by a single mutated protein, huntingtin, which slowly kills brain cells.
ā³ Slow but relentless: Without treatment, symptoms appear in your 30s–40s and the disease is usually fatal within 20 years.

One of the most devastating diseases finally has a treatment that can slow its progression and transform lives, tearful doctors tell BBC.

Sexual health is a key part of overall health, yet many people face barriers to care, accurate information, and early di...
18/09/2025

Sexual health is a key part of overall health, yet many people face barriers to care, accurate information, and early diagnosis.

Every year, millions of sexually transmitted infections (STIs) go undetected, and conditions like HIV, HPV, and other infections can have serious long-term consequences if not caught early.

Currently, around the world:
• HPV causes 4.5% of all cancer cases
• 1 in 7 people with HIV are unaware that they have the condition
• Antimicrobial resistance is a major threat to the reliability of established gonorrhea treatments

Prevention, testing, and early treatment save lives, but to improve outcomes, we need research that reflects everyone’s experiences, tracks trends accurately, and helps healthcare providers deliver care that works for all communities.

This Sexual Health Awareness Week, the message is clear: better awareness, better access, and better research mean healthier communities. Understanding sexual health isn’t just a personal matter, it’s a public health priority.

This International Day of Charity, we want to talk about how charities help make medical research happen and how that be...
05/09/2025

This International Day of Charity, we want to talk about how charities help make medical research happen and how that benefits patients.

Last year in the UK, 180,712 people took part in clinical studies or trials funded by charities. But their role goes far beyond funding.

Many charities:
šŸ“‹ Keep volunteer databases so it’s easier to find research opportunities
šŸ“£ Share studies in newsletters and on social media
🌐 Highlight research on their websites to reach more people

These efforts help connect patients with the studies that need them. At Research Grid, our Inclusive platform makes it even easier for charities to work with researchers by building relationships and helping more people hear about relevant trials sooner.

Charities make research possible. Together with the right technology, they can help even more patients take part and shape the future of medicine.

August is globally recognized as Psoriasis Awareness Month or Psoriasis Action Month.Affecting between 2–3% of the popul...
21/08/2025

August is globally recognized as Psoriasis Awareness Month or Psoriasis Action Month.

Affecting between 2–3% of the population, psoriasis happens when an overactive immune system speeds up the skin cell cycle, causing new cells to replace in just a few days instead of the usual 21–28.

The result is a build-up of immature cells that form raised, flaky patches, often itchy and sometimes even affecting the joints.

More research is needed to not only transform treatment options but also better understand the disease itself and make a real impact for people living with psoriasis.

At Inclusive, we’re working to support that. Within our network, there are over 530 community groups dedicated to psoriasis, making it easier for researchers to connect directly with people impacted and ensure that studies reflect the real experiences of those living with the condition.

šŸ” $9.23 million is the average cost of a data breach in the healthcare industry. But it’s not just about money, it’s abo...
14/08/2025

šŸ” $9.23 million is the average cost of a data breach in the healthcare industry. But it’s not just about money, it’s about trust.

As more trials go digital, remote participation, real-time data sharing, and connected systems are making research more accessible. However, they also require careful attention to data privacy.

30% of clinical trial participants worry about data theft. To build trust, and keep it, we need technology that protects people:
⚔ AI-powered threat detection
šŸ¤– Fewer manual errors, faster anonymization
šŸ¤ Secure integration between different systems

As clinical research moves toward a digital future, ensuring robust data security will be critical to earning and maintaining patient trust.

Read more about it in our latest article:

Clinical trials are increasingly leveraging digital tools, real-time data sharing, and seamless collaboration to accelerate trial…

The success of a clinical trial often hinges on how quickly it gets started. With up to 86% of trials experiencing delay...
08/08/2025

The success of a clinical trial often hinges on how quickly it gets started.

With up to 86% of trials experiencing delays in the start-up process, there is a growing urgency for faster, smarter trial initiation. The UK government, for example, aims to cut startup times from 250 days to under 150 by March 2026.

Last week, we launched our new Site Feasibility Solution to help make these goals a reality.
āœ… Real-world data and a global network of 96,000+ communities
āœ… Reduce 6 months of manual work to instant insights
āœ… Feasibility built for speed, compliance, and inclusivity

šŸ‘‰ Read the full press release to learn how this new solution supports more efficient, scalable trial startups:
https://apnews.com/press-release/pr-newswire/clinical-trial-site-feasibility-from-6-months-to-minutes-with-research-grids-new-automation-tool-25145809e3eeb68341618570495cea80

Research Grid (R.grid) launches new Site Feasibility solution to accelerate trial startups and expand global patient access The tool uses real-world data paired with Research Grid's proprietary network of over 97,000 communities A process that once took six months can now be done in minutes thanks t...

šŸš€ Making it easier for clinical trials to reach youMany clinical trials start late or don’t happen in the right places. ...
30/07/2025

šŸš€ Making it easier for clinical trials to reach you

Many clinical trials start late or don’t happen in the right places. That means people miss out on opportunities for care and new treatments.

We built a tool to help researchers fix that.

Our new Site Feasibility feature helps trials:
šŸ“ Find where patients actually are
ā±ļø Start faster, with less waiting
šŸŒ Reach more people in more communities

We’re making it easier for people like you to join trials that matter.

šŸ‘‰ Learn more: https://inclusive.health/solutions/site-feasibility

The theme for World Hepatitis Day 2025: Let’s break it downApproximately 300 million people worldwide live with viral he...
28/07/2025

The theme for World Hepatitis Day 2025: Let’s break it down

Approximately 300 million people worldwide live with viral hepatitis, an infection that damages the liver and which is still often underdiagnosed and undertreated.

Just 1 in 4 people with Hepatitis B and 1 in 2 with Hepatitis C know they have it, and even fewer are receiving treatment.

This year’s theme ā€˜Let’s break it down’ focuses on breaking down barriers to treatment, but what about the barriers to research?

More research is urgently needed to develop better treatment, diagnostic, and prevention strategies. Many of the communities hardest hit by hepatitis are routinely overlooked in clinical trials.

Although Africa accounts for an estimated 70% of new Hepatitis B infections globally, only about 1% of Hepatitis B clinical trials involve the continent.

To make real progress in combatting this condition, researchers need these communities on their side. Smart outreach and technology make it easier to build connections and create research opportunities that include everyone. See how Inclusive can support this at inclusive.health.

Source: https://www.who.int/westernpacific/newsroom/events/detail/2025/07/28/western-pacific-events/world-hepatitis-day-2025
https://pubmed.ncbi.nlm.nih.gov/38367632/

Saying ā€˜yes’ to a clinical trial can feel like a big step, and participants should never feel rushed or confused when ma...
18/07/2025

Saying ā€˜yes’ to a clinical trial can feel like a big step, and participants should never feel rushed or confused when making that decision.

That’s where eConsent comes in.

eConsent (electronic consent) is a digital way to get informed consent from research participants. It replaces paper forms with an online platform that lets people read study details, ask questions, and review and sign consent forms. Instead of flipping through stacks of paper, participants can read everything on their phone, tablet, or computer, at their own pace and in their own space.

People who use eConsent say it’s easier to understand, less stressful, and more respectful of their time. Participants can take as long as they need, re-read anything that’s unclear, and ask questions when they’re ready.

That’s why Research Grid has built an eConsent experience that’s clear, easy to use, and smart enough to catch anything missing: https://trialengine.ai/solutions/econsent

The consent form isn’t just a box to tick. It’s where trust begins.

šŸ„ Community-based healthcare is getting a major boost in the UK, with the new 10-Year Health Plan set to bring diagnosti...
11/07/2025

šŸ„ Community-based healthcare is getting a major boost in the UK, with the new 10-Year Health Plan set to bring diagnostics, mental health services, rehabilitation, and routine treatments directly into local neighborhood hubs.

The goal is to make care more accessible, preventative, and patient-centered.

At Research Grid, we believe clinical research should follow the same path: designed around real communities, embedded where people live, and shaped by local voices from the very start.

With our Inclusive platform, trial recruitment can be truly community-driven:

šŸ“ Engage thousands of local patient groups instantly
šŸ“ Build lasting relationships with community networks
šŸ“ Adapt outreach for cultural and accessibility needs
šŸ“ Automate every step, from first contact to follow-up

Healthcare doesn’t only happen in hospitals, and neither should trials. When research meets people where they are, trials become faster, more inclusive, and more successful.

The Prime Minister launches a new era for the NHS, bringing more easily accessible care closer to home.

AI is transforming clinical trials, but while 49% of biopharma companies are investing in AI, most aren’t applying it wh...
03/07/2025

AI is transforming clinical trials, but while 49% of biopharma companies are investing in AI, most aren’t applying it where it matters most: the back office. ļæ½

Operations play a vital role in getting new medicines to the right people faster and at lower cost. But legacy systems, called Clinical Trial Management Systems (CTMS), rely on manual input, which leads to errors and delays.ļæ½In fact, delays due to manual trial operations cost an average of $400M, per trial. This budget could be spent elsewhere to improve patient outcomes. The solution to this is purpose-built, scalable technology.

TrialEngine, our clinical trial automation system (CTAS), automates operations in minutes, giving trial teams full control over workflows and budgets. Here’s what that means for you:ļæ½

šŸ’Š New medicines reach the right people faster
šŸ§‘ā€šŸ”¬ Researchers are freed from tedious and costly admin, giving them time to focus on the participants
šŸš€ Trials run faster, and succeed more often

Address

London

Telephone

+442035762539

Alerts

Be the first to know and let us send you an email when R.grid posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to R.grid:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram